NewGenn Science, 258, Dosan-ro, Seo-gu, Daejeon-si, South Korea.
J Pharm Sci. 2020 Mar;109(3):1421-1423. doi: 10.1016/j.xphs.2019.12.010. Epub 2019 Dec 19.
The terminal half-life (T) of a biphasic declining plasma concentration-time profile of a drug after intravenous administration is proportional to a ratio between its systemic clearance (CL) and volume of distribution at pseudo-distribution equilibrium (Vd). Due to lack of understanding of Vd simply known as a proportionality constant between the amount of drug in the body and its plasma concentration during the terminal phase, the effects of various physiologically based pharmacokinetic parameters of drug on T could not have been evaluated. The objective of the current study is to offer a new theoretical ground, using the Taylor series expansion, for a better understanding of relationships among T, CL, distributional clearance (CL) and volumes of distribution in the tissue compartment (V) and at steady state (Vd) of drug in a 2-compartment model after intravenous administration. Similar CL and Vd yet different T of drugs found in pharmacokinetic studies might be due to differences in CL and V of those drugs. In conclusion, the new equation (T ≈ 0.693 (Vd/CL + V/CL) explicitly shows how the physiologically based pharmacokinetic parameters of drug could affect its T after intravenous administration.
静脉注射后双相下降的药物血浆浓度时间曲线的末端半衰期(T)与全身清除率(CL)和假性分布平衡时分布容积(Vd)之间的比例成正比。由于对 Vd 的理解不足,Vd 通常被简单地视为药物在体内的量与其在终末相时血浆浓度之间的比例常数,因此无法评估药物的各种基于生理的药代动力学参数对 T 的影响。本研究的目的是使用泰勒级数展开,为更好地理解静脉注射后 2 室模型中药物的 T、CL、分布清除率(CL)和组织隔室(V)及稳态时的分布容积(Vd)之间的关系提供一个新的理论基础。在药代动力学研究中发现的具有相似 CL 和 Vd 但 T 不同的药物可能是由于这些药物的 CL 和 V 不同所致。总之,新的方程(T≈0.693(Vd/CL+V/CL)明确表明了药物的基于生理的药代动力学参数如何影响其静脉注射后的 T。